Drug Delivery Devices Market Forecast 2025–2034: Where Businesses Should Invest Next

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Drug Delivery Devices Market From 2025 To 2034?

The domain of drug delivery devices has witnessed robust expansion lately, with its valuation projected to advance from $91.03 billion in 2024 to $95.99 billion the following year, reflecting a consistent compound annual growth rate of 5.4%; this upward trajectory during the past period stems from several factors, notably the swift increase in the senior population demographic, the proliferation of medical treatment centers, economic development taking root in developing economies, and amplified spending allocated to healthcare services.

Anticipating robust expansion, the market associated with drug delivery apparatuses is projected to attain a valuation of $122.16 billion by 2029, reflecting a compound annual growth rate of 6.2% throughout the ensuing period; this surge is fundamentally driven by the rising incidence of long-term ailments, a heightened need for injectable pharmaceuticals, greater overall requirement for drug administration systems, and the unforeseen outbreak of serious infectious conditions; furthermore, pivotal shifts influencing this market during the projection timeframe involve substantial allocations toward microneedle-based drug administration advancements, ongoing investigations into self-administering injection tools, a strategic emphasis on consolidation through corporate buyouts and mergers, alongside considerable investment directed towards developing wearable drug delivery technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Are The Key Drivers Of Growth In The Drug Delivery Devices Market?

The expanding incidence of long-term ailments, encompassing conditions such as heart disease, diabetes, malignancies, and further illnesses, is anticipated to be a principal impetus for the expansion of the drug delivery devices sector; for illustration, data from the National Library of Medicine, a US federal medical repository, indicated in January 2023 that the population aged fifty and above in the United States suffering from a minimum of one chronic ailment is forecast to double, escalating from 71.522 million in the year 2020 to 142.66 million by the year 2050. Considering the diverse avenues available for introducing medical substances into the body, novel drug administration technologies are becoming significantly important within the pharmaceutical realm, prompting heightened global research and development efforts correlative to the escalating frequency of these health issues; consequently, numerous pharmaceutical entities are concentrating resources on various drug conveyance methods aiming to secure superior competitive edges and enhanced efficacy for their commercialized pharmaceuticals, thus, the mounting occurrence of chronic conditions directly translates to greater utilization of medicinal treatments, which serves as a propelling force for the ascending trajectory of the drug delivery devices market.

What Are The Leading Segments Analyzed In The Drug Delivery Devices Market?

The drug delivery devicesmarket covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Which Key Trends Are Expected To Influence The Drug Delivery Devices Market In The Coming Years?

Key players within the drug delivery device sector are concentrating their efforts on creating cutting-edge apparatus, specifically internet-connected autoinjectors, aiming to secure a stronger market position. These autoinjectors are medical instruments engineered to allow patients to inject a predetermined amount of medicine themselves. To illustrate, a significant development occurred in May 2022 when Jabil Healthcare, a US entity specializing in healthcare manufacturing services, introduced the Qfinity autoinjector system, which is a drug delivery mechanism intended for repeated use. Distinguished by its simplicity, modularity, and reusability for subcutaneous self-injection, the Qfinity platform presents an economical substitute against existing market options, simultaneously championing environmentally conscious drug administration across the pharmaceutical landscape. Its adaptable structure accommodates a range of drug volumes and thicknesses, presenting a design centered around the user that delivers savings up to 65 percent in the cost per injection when contrasted with top disposable autoinjectors. Furthermore, this robust Qfinity instrument is capable of facilitating more than a hundred injections and is compatible with drug cartridges that are pre-filled and disposable, either in 1 mL or 2.25 mL sizes. The reduced consumption of materials and components consequently yields substantial environmental and economic benefits, estimated to include a 65 percent lowering in the expense per injection, a 60 percent smaller environmental impact, a 50 percent reduction in the factory footprint required for production, and a 70 percent drop in necessary initial investment spending.

Who Are The Key Multinational Companies Dominating The Drug Delivery Devices Market?

Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

What Are The Regional Market Dynamics Impacting The Drug Delivery Devices Industry?

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Devices Market 2025, By The Business Research Company

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Injectable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Liposomal Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795